Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada ,Poland ,Toronto ,Ontario ,Richmond Hill ,Warsaw ,L67 ,Canadian ,Christopher Maciejewski ,Artur Gabor ,Jacek Antas ,Frank Michalargias ,Jerzy Leszczynski ,Manual Sciences ,Silesian University In Wroclaw ,Warsaw Institute Of Technology ,Warsaw School Of Economics ,Helix Biopharma Corp ,Helix Biopharma ,Chief Executive Officer ,Warsaw Institute ,Chief Medical Officer ,Medevac Canada ,Silesian University ,Applied Medical Manual ,Warsaw School ,Chief Executive ,Chief Financial Officer ,Looking Statements ,Annual Information Form ,Helix ,Iopharma ,Orp ,Nnounces ,Appointment ,Permanent ,Independent ,Board ,Members ,